Protocol-Based Standardized Endocrinological Evaluation of Children With Traumatic Brain Injury: A Quality

Jayalakshmi Narayan Bhat1,2, Abbie Amato3, Scott Schultz3

  • 1Department of Pediatric Endocrinology, Louisiana State University Health Science Center, Shreveport, LA, USA.

Clinical Pediatrics
|February 8, 2024
PubMed

Insights

Traumatic brain injury (TBI) can cause neuroendocrine dysfunction. A quality improvement initiative improved pediatric endocrine referral and follow-up rates in children with TBI.

Area of Science:

  • Pediatric Endocrinology
  • Neuroendocrinology
  • Traumatic Brain Injury

Background:

  • Traumatic brain injury (TBI) can disrupt the hypothalamo-pituitary axis, leading to neuroendocrine dysfunction.
  • Post-traumatic hypothalamo-pituitary axis dysfunction (HPAD) affects a significant portion of children following TBI, necessitating longitudinal follow-up.
  • Standardized protocols are crucial for managing endocrine sequelae in pediatric TBI cases.

Purpose of the Study:

  • To evaluate the impact of a quality improvement (QI) initiative on the management of hypothalamo-pituitary axis dysfunction (HPAD) in children with TBI.
  • To assess the prevalence of HPAD and the rates of pediatric endocrine referral and follow-up before and after implementing a standardized guidance protocol.

Main Methods:

  • A pre-QI (retrospective) and QI (prospective) phase study design was employed.
  • Data on HPAD prevalence and endocrine referral rates were collected during the pre-QI phase.
  • A guidance protocol for pediatric endocrine referral, evaluation, and follow-up was implemented, followed by prospective data collection on outcomes and process measures.

Main Results:

  • In the pre-QI phase, 30% of children with TBI had limited endocrine evaluation and 4% had transient cranial diabetes insipidus.
  • Following QI protocol implementation, both outcome measures (HPAD prevalence, referral, and follow-up rates) and process measures increased to 75%.
  • The QI phase included 8 children, with demographic data similar to the pre-QI phase (n=27).

Conclusions:

  • The quality improvement initiative, integrating a standardized endocrinological approach, significantly improved pediatric endocrinology referral and follow-up rates in children with TBI.
  • While the current cohort showed a lower HPAD prevalence, this may be attributed to under-evaluation and a smaller sample size in the QI phase.
  • Longitudinal follow-up and standardized protocols are essential for managing neuroendocrine dysfunction after pediatric TBI.
Abstract